← EPO Patent Bulletin

BLOOD-BRAIN BARRIER PERMEABLE HETERODUPLEX NUCLEIC ACID

Publication EP3517610A1 Kind: A1 Mar 18, 2026

Applicants

National University Corporation Tokyo Medical and Dental University

Inventors

YOKOTA Takanori, NAGATA Tetsuya

Abstract

The present invention provides a composition and a method for efficiently delivering a nucleic acid agent to the central nervous system and/or the retina and bringing about antisense effects. Provided is a composition for reducing the expression level of a target transcription product in the central nervous system and/or retina of a subject, the composition including a nucleic acid complex that includes a first nucleic acid strand and a second nucleic acid strand, wherein: the first nucleic acid strand comprises a base sequence capable of hybridizing with at least part of the target transcription product and has an antisense effect on the target transcription product; the second nucleic acid strand comprises a base sequence complementary to the first nucleic acid strand and is conjugated to tocopherol, cholesterol, or an analog thereof; and the first nucleic acid strand is annealed to the second nucleic acid strand.

IPC Classifications

C12N 15/113 20100101AFI20200421BHEP C12N 15/11 20060101ALI20200421BHEP A61K 31/713 20060101ALI20200421BHEP A61K 31/7115 20060101ALI20200421BHEP A61K 31/7125 20060101ALI20200421BHEP A61K 31/712 20060101ALI20200421BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR